These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15324862)

  • 1. The role of positron emission tomography with [18F]fluorodeoxyglucose in the evaluation of the epilepsies.
    Henry TR; Votaw JR
    Neuroimaging Clin N Am; 2004 Aug; 14(3):517-35, ix. PubMed ID: 15324862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semiquantitative analysis of interictal glucose metabolism between generalized epilepsy and localization related epilepsy.
    Hikima A; Mochizuki H; Oriuchi N; Endo K; Morikawa A
    Ann Nucl Med; 2004 Oct; 18(7):579-84. PubMed ID: 15586631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography in epileptogenic hypothalamic hamartomas.
    Ryvlin P; Ravier C; Bouvard S; Mauguire F; Le Bars D; Arzimanoglou A; Petit J; Kahane P
    Epileptic Disord; 2003 Dec; 5(4):219-27. PubMed ID: 14975790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Positron emission tomography: which indications, which benefits?].
    Chassoux F; Chiron C
    Neurochirurgie; 2008 May; 54(3):219-25. PubMed ID: 18430441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of interictal fluorine-18-fluorodeoxyglucose PET in partial epilepsy.
    Henry TR; Engel J; Mazziotta JC
    J Nucl Med; 1993 Nov; 34(11):1892-8. PubMed ID: 8229230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain molecular imaging in pharmacoresistant focal epilepsy: Current practice and perspectives.
    Verger A; Lagarde S; Maillard L; Bartolomei F; Guedj E
    Rev Neurol (Paris); 2018; 174(1-2):16-27. PubMed ID: 28595975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic changes of subcortical structures in intractable focal epilepsy.
    Benedek K; Juhász C; Muzik O; Chugani DC; Chugani HT
    Epilepsia; 2004 Sep; 45(9):1100-5. PubMed ID: 15329075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET tracer technology for monitoring focal epilepsies.
    Koepp MJ
    Expert Rev Med Devices; 2007 Mar; 4(2):191-200. PubMed ID: 17359224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography and single photon emission computed tomography in epilepsy care.
    Henry TR; Van Heertum RL
    Semin Nucl Med; 2003 Apr; 33(2):88-104. PubMed ID: 12756642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced changes in cerebral glucose consumption in bifrontal epilepsy.
    Matheja P; Weckesser M; Debus O; Löttgen J; Schuierer G; Schober O; Kurlemann G
    Epilepsia; 2000 May; 41(5):588-93. PubMed ID: 10802765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter abnormalities revealed by DTI correlate with interictal grey matter FDG-PET metabolism in focal childhood epilepsies.
    Lippé S; Poupon C; Cachia A; Archambaud F; Rodrigo S; Dorfmuller G; Chiron C; Hertz-Pannier L
    Epileptic Disord; 2012 Dec; 14(4):404-13. PubMed ID: 23248049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is central benzodiazepine receptor imaging useful for the identification of epileptogenic foci in localization-related epilepsies?
    Goethals I; Van de Wiele C; Boon P; Dierckx R
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):325-8. PubMed ID: 12552355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of FDG-PET hypometabolism and SEEG epileptogenicity mapping in patients with drug-resistant focal epilepsy.
    Lamarche F; Job AS; Deman P; Bhattacharjee M; Hoffmann D; Gallazzini-Crépin C; Bouvard S; Minotti L; Kahane P; David O
    Epilepsia; 2016 Dec; 57(12):2045-2055. PubMed ID: 27861778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography in partial epilepsies: the clinical point of view.
    Koutroumanidis M; Binnie CD; Panayiotopoulos CP
    Nucl Med Commun; 1998 Dec; 19(12):1123-6. PubMed ID: 9885801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use and impact of positron computed tomography scanning in epilepsy.
    Mazziotta JC; Engel J
    Epilepsia; 1984; 25 Suppl 2():S86-104. PubMed ID: 6430693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18FDG-PET in epilepsies of infantile onset with pharmacoresistant generalised tonic-clonic seizures.
    Korinthenberg R; Bauer-Scheid C; Burkart P; Martens-Le Bouar H; Kassubek J; Juengling FD
    Epilepsy Res; 2004 Jun; 60(1):53-61. PubMed ID: 15279870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of [F]FDG-PET in nonrefractory partial epilepsy.
    Weitemeyer L; Kellinghaus C; Weckesser M; Matheja P; Loddenkemper T; Schuierer G; Schober O; Ringelstein EB; Lüdemann P
    Epilepsia; 2005 Oct; 46(10):1654-60. PubMed ID: 16190939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we increase the yield of FDG-PET in the preoperative work-up for epilepsy surgery?
    van't Klooster MA; Huiskamp G; Zijlmans M; Debets RM; Comans EF; Bouvard S; Ryvlin P; Leijten FS
    Epilepsy Res; 2014 Aug; 108(6):1095-105. PubMed ID: 24893829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interictal cerebral metabolism in partial epilepsies of neocortical origin.
    Henry TR; Sutherling WW; Engel J; Risinger MW; Levesque MF; Mazziotta JC; Phelps ME
    Epilepsy Res; 1991; 10(2-3):174-82. PubMed ID: 1817957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [18F]fluorodeoxyglucose positron emission tomography in refractory complex partial seizures.
    Theodore WH; Newmark ME; Sato S; Brooks R; Patronas N; De La Paz R; DiChiro G; Kessler RM; Margolin R; Manning RG
    Ann Neurol; 1983 Oct; 14(4):429-37. PubMed ID: 6416141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.